BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34105601)

  • 1. Epidemiological profile of women with gynecological cancer in brachytherapy: a cross-sectional study.
    Rosa LMD; Hames ME; Dias M; Miranda GM; Bagio CB; Santos MJD; Kalinke LP
    Rev Bras Enferm; 2021; 74(5):e20200695. PubMed ID: 34105601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers.
    Ota T; Takeshima N; Tabata T; Hasumi K; Takizawa K
    Br J Cancer; 2007 Oct; 97(8):1058-62. PubMed ID: 17895888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of combination of (252)Cf neutron intracavitary brachytherapy and external beam radiotherapy for 110 cervical cancer patients].
    Bu J; Li R; Song W; Cao JX; Wang YX
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):619-21. PubMed ID: 21122417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cervical carcinoma with high-dose rate intracavitary brachytherapy: two years follow-up study.
    Das D; Chaudhuri S; Deb AR; Aich RK; Gangopadhyay S; Ray A
    Asian Pac J Cancer Prev; 2011; 12(3):807-10. PubMed ID: 21627388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cervix cancer despite cytology. A new critical look at cervix cancer prevention].
    Prömer H; Heiss O; Staudach A; Thurner J
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():269-70. PubMed ID: 8118308
    [No Abstract]   [Full Text] [Related]  

  • 8. [A rare site of distant metastases of progressive cervix cancer].
    Schumacher A; Rohde E
    Zentralbl Gynakol; 1992; 114(1):30-2. PubMed ID: 1585743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis.
    Sakurai H; Mitsuhashi N; Takahashi M; Akimoto T; Muramatsu H; Ishikawa H; Imai R; Yamakawa M; Hasegawa M; Niibe H
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1136-44. PubMed ID: 11483322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in outcome for cervical cancer patients treated with or without brachytherapy.
    Karlsson J; Dreifaldt AC; Mordhorst LB; Sorbe B
    Brachytherapy; 2017; 16(1):133-140. PubMed ID: 27836496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for treatment outcome and early and late radiation reactions.
    Bohr Mordhorst L; Karlsson L; Bärmark B; Sorbe B
    Int J Gynecol Cancer; 2014 Sep; 24(7):1268-75. PubMed ID: 25078336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of pain and distress during high-dose-rate intracavity brachytherapy for cervical cancer.
    Kwekkeboom KL; Dendaas NR; Straub M; Bradley KA
    J Support Oncol; 2009; 7(3):108-14. PubMed ID: 19507459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical radiotherapy for carcinoma of the uterine cervix using high dose rate brachytherapy--a preliminary report.
    Khoo-Tan HS; Chua EJ
    Ann Acad Med Singap; 1996 May; 25(3):367-70. PubMed ID: 8876903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
    Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
    Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
    Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
    Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
    Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.